232 related articles for article (PubMed ID: 8452169)
1. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1993 Mar; 94(3A):131S-135S. PubMed ID: 8452169
[TBL] [Abstract][Full Text] [Related]
2. Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
Ulmer W
Am J Med; 1993 Mar; 94(3A):136S-141S. PubMed ID: 8452170
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
4. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
Smith JW; Nichols RL
Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
[TBL] [Abstract][Full Text] [Related]
7. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
8. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
Powers RD
Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days.
Butler T; Lolekha S; Rasidi C; Kadio A; del Rosal PL; Iskandar H; Rubinstein E; Pastore G
Am J Med; 1993 Mar; 94(3A):187S-194S. PubMed ID: 8452179
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
12. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
Pittman W; Moon JO; Hamrick LC; Cox CE; Clark J; Childs S; Pizzuti D; Fredericks J; St Clair P
Am J Med; 1993 Mar; 94(3A):101S-104S. PubMed ID: 8452163
[TBL] [Abstract][Full Text] [Related]
14. Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
Farkas SA
Am J Med; 1993 Mar; 94(3A):142S-149S. PubMed ID: 8452171
[TBL] [Abstract][Full Text] [Related]
15. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fleroxacin and amoxicillin in the treatment of uncomplicated urinary tract infections in women.
Whitby M; Brown P; Silagy C; Rana C
Am J Med; 1993 Mar; 94(3A):97S-100S. PubMed ID: 8452191
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
18. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
[TBL] [Abstract][Full Text] [Related]
19. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
20. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
Pummer K
Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
